Barbara Langer

782 total citations
17 papers, 572 citations indexed

About

Barbara Langer is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Barbara Langer has authored 17 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 4 papers in Immunology. Recurrent topics in Barbara Langer's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Hepatitis Viruses Studies and Epidemiology (4 papers). Barbara Langer is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Hepatitis Viruses Studies and Epidemiology (4 papers). Barbara Langer collaborates with scholars based in Germany, United Kingdom and United States. Barbara Langer's co-authors include Gert Frösner, Anita Zeller, B. Wiebecke, H. Meisner, John Hess, Manfred Vogt, A. Sendl, Thomas Lang, Albrecht von Brunn and Theoni Petropoulou and has published in prestigious journals such as New England Journal of Medicine, Journal of Neurochemistry and Vaccine.

In The Last Decade

Barbara Langer

17 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Langer Germany 9 461 457 42 36 36 17 572
Uta Naumann Germany 12 578 1.3× 575 1.3× 36 0.9× 70 1.9× 30 0.8× 32 680
Hoofnagle Jh United States 10 522 1.1× 505 1.1× 21 0.5× 49 1.4× 28 0.8× 20 603
J. H. Hoofnagle United States 11 295 0.6× 275 0.6× 54 1.3× 64 1.8× 38 1.1× 14 414
Giovanna Fattovich Italy 6 498 1.1× 562 1.2× 67 1.6× 100 2.8× 24 0.7× 7 670
Minoru Horikita Japan 5 713 1.5× 743 1.6× 40 1.0× 83 2.3× 30 0.8× 6 787
T Sodeyama Japan 10 439 1.0× 464 1.0× 19 0.5× 43 1.2× 17 0.5× 19 536
K Ohba Japan 4 397 0.9× 420 0.9× 21 0.5× 55 1.5× 14 0.4× 6 474
Atsushi Ozasa Japan 8 264 0.6× 274 0.6× 62 1.5× 38 1.1× 12 0.3× 10 377
Stephen Delaney United States 12 163 0.4× 173 0.4× 34 0.8× 31 0.9× 113 3.1× 19 380
Galia Askarieh Sweden 8 262 0.6× 311 0.7× 43 1.0× 28 0.8× 96 2.7× 11 438

Countries citing papers authored by Barbara Langer

Since Specialization
Citations

This map shows the geographic impact of Barbara Langer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Langer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Langer more than expected).

Fields of papers citing papers by Barbara Langer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Langer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Langer. The network helps show where Barbara Langer may publish in the future.

Co-authorship network of co-authors of Barbara Langer

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Langer. A scholar is included among the top collaborators of Barbara Langer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Langer. Barbara Langer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Alsina, Katherina M., Mohit Hulsurkar, Chunxia Yao, et al.. (2018). Novel role of the protein phosphatase 1 regulatory subunit PPP1R3A in atrial fibrillation. Journal of Molecular and Cellular Cardiology. 124. 108–108. 1 indexed citations
2.
Langer, Barbara, et al.. (2015). Zelltherapeutika – eine innovative Therapieoption in der Ophthalmologie. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 58(11-12). 1259–1264. 6 indexed citations
3.
Langer, Barbara, Matthias Renner, Jürgen Scherer, Silke Schüle, & Klaus Cichutek. (2012). Safety Assessment of Biolistic DNA Vaccination. Methods in molecular biology. 940. 371–388. 9 indexed citations
4.
Zuckerman, Jane N. & Barbara Langer. (2005). Hepatitis B vaccination in a school age population: a feasibility study. Journal of Medical Virology. 76(1). 47–54. 14 indexed citations
5.
Langer, Barbara, et al.. (2003). Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects. Journal of Medical Virology. 69(3). 350–356. 24 indexed citations
6.
Bevitt, Debra J., K N Agarwal, Theoni Petropoulou, et al.. (2002). Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody. Journal of Medical Virology. 68(3). 335–342. 39 indexed citations
7.
Hedlund, J., Barbara Langer, Helle Bossen Konradsen, & Åke Örtqvist. (2001). Negligible adjuvant effect for antibody responses and frequent adverse events associated with IL-12 treatment in humans vaccinated with pneumococcal polysaccharide. Vaccine. 20(1-2). 164–169. 15 indexed citations
8.
Langer, Barbara, et al.. (2000). Distinct Internalization of M2 Muscarinic Acetylcholine Receptors Confers Selective and Long‐Lasting Desensitization of Signaling to Phospholipase C. Journal of Neurochemistry. 74(4). 1721–1730. 27 indexed citations
9.
Vogt, Manfred, Thomas Lang, Gert Frösner, et al.. (2000). Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery Before the Implementation of Blood-Donor Screening. Survey of Anesthesiology. 44(3). 154–154. 31 indexed citations
10.
Vogt, Manfred, Thomas Lang, Gert Frösner, et al.. (1999). Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening. New England Journal of Medicine. 341(12). 866–870. 346 indexed citations
11.
Langer, Barbara, Gert Frösner, & Albrecht von Brunn. (1997). Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland. Journal of Viral Hepatitis. 4(5). 339–349. 37 indexed citations
12.
Langer, Barbara. (1996). High immunogenicity and good tolerability of a new hepatitis A vaccine candidate. Vaccine. 14(12). 1089–1091. 3 indexed citations
13.
14.
Re, Falk, et al.. (1977). Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.. PubMed. 20(1). 25–30. 4 indexed citations
15.
Bennett, Robert M., Barbara Langer, & Elena Molina. (1976). Nucleoprotein-coated Latex Particles in the Serologic Diagnosis of Systemic Lupus Erythematosus: A Comparative Clinical and Serologic Study. American Journal of Clinical Pathology. 66(4). 743–745. 3 indexed citations
16.
Re, Falk, et al.. (1975). Oral bacille Calmette Guérin immunostimulation in malignant melanoma.. PubMed. 141(5). 747–54. 6 indexed citations
17.
Falk, R. E., et al.. (1975). Use of oral and intraperitoneal BCG in the treatment of malignant melanoma and adenocarcinoma.. PubMed. 4(1). 39–45. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uta Naumann Breakdown of academic impact, for papers by Hoofnagle Jh Breakdown of academic impact, for papers by J. H. Hoofnagle Breakdown of academic impact, for papers by Giovanna Fattovich Breakdown of academic impact, for papers by Minoru Horikita Breakdown of academic impact, for papers by T Sodeyama Breakdown of academic impact, for papers by K Ohba Breakdown of academic impact, for papers by Atsushi Ozasa Breakdown of academic impact, for papers by Stephen Delaney Breakdown of academic impact, for papers by Galia Askarieh
Rankless by CCL
2026